Fig. 1From: AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)The IgE isotype uniquely encompasses effector function in the pathophysiologies of allergic reactions, parasitosis, and tumour defenceBack to article page